Document Detail


DRESS-syndrome on sulfasalazine and naproxen treatment for juvenile idiopathic arthritis and reactivation of human herpevirus 6 in an 11-year-old Caucasian boy.
MedLine Citation:
PMID:  20831538     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
DRESS-syndrome (Drug Rash with Eosinophilia and Systemic Symptoms) is a severe drug-induced hypersensitivity syndrome characterized by diffuse maculopapular rash, lymphadenopathy, multivisceral involvement, eosinophilia and atypical lymphocytes with a mortality rate of 10-40% (Seminars in Cutaneous Medicine and Surgery, 1, 250). It is described in adults treated with aromatic antiepileptics and less frequently with sulphonamides, and non-steroidal anti-inflammatory drugs (Clinics in Dermatology, 23, 171; Pediatrics, 108, 485). We report on an 11-year-old Caucasian boy hospitalized with a skin eruption, lymphadenopathy, acute hepatitis, renal tubular involvement, haematological abnormalities and human-herpevirus-6 reactivation, treated with sulfasalazine and naproxen for juvenile idiopathic arthritis (JIA). This is the first report in children with rheumatic disease and highlights the possibility of sulfasalazine and naproxen-induced-DRESS-syndrome in children with JIA.
Authors:
E Piñana; S H Lei; R Merino; M Melgosa; R De La Vega; E Gonzales-Obeso; E Ramírez; A Borobia; A Carcas
Related Documents :
12917188 - Asymptomatic optic neuropathy associated with churg-strauss syndrome.
3988278 - Acute febrile neutrophilic dermatosis (sweet's syndrome) associated with lymphoma.
11147758 - Eosinophilic cholecystitis as a possible late manifestation of the eosinophilia-myalgia...
9156128 - Acute fulminant neuropathy in a patient with churg-strauss syndrome.
1953968 - Reversible pathologic jealousy (othello syndrome) associated with amantadine.
20840798 - Estimation of dead space fraction can be simplified in the acute respiratory distress s...
Publication Detail:
Type:  Case Reports; Journal Article    
Journal Detail:
Title:  Journal of clinical pharmacy and therapeutics     Volume:  35     ISSN:  1365-2710     ISO Abbreviation:  J Clin Pharm Ther     Publication Date:  2010 Jun 
Date Detail:
Created Date:  2010-09-13     Completed Date:  2010-12-17     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8704308     Medline TA:  J Clin Pharm Ther     Country:  England    
Other Details:
Languages:  eng     Pagination:  365-70     Citation Subset:  IM    
Affiliation:
Clinical Pharmacology Department, Hospital Universitario La Paz, School of Medicine, Universidad Autónoma de Madrid, Spain.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Anti-Inflammatory Agents, Non-Steroidal / adverse effects,  therapeutic use
Arthritis, Juvenile Rheumatoid / drug therapy
Child
Drug Eruptions / etiology*
Drug Therapy, Combination
Herpesvirus 6, Human / isolation & purification
Humans
Male
Naproxen / adverse effects*,  therapeutic use
Roseolovirus Infections / virology
Sulfasalazine / adverse effects*,  therapeutic use
Syndrome
Virus Activation / drug effects
Chemical
Reg. No./Substance:
0/Anti-Inflammatory Agents, Non-Steroidal; 22204-53-1/Naproxen; 599-79-1/Sulfasalazine

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Hepatotoxicity of alpha-methyldopa in pregnancy.
Next Document:  What do the suffixes--XR, ER, Chrono, Chronosphere--really mean as it pertains to modified-release a...